Previous tuberculosis, hepatitis C virus and lichen planus: A report of 10 cases, a causal or casual link?

Panminerva Medica

Volumn 42, Issue 1, 2000, Pages 77-81

  Pellicano, R ^b,e   Palmas, F ^a   Leone, N ^a   Vanni, E ^a   Carrozzo, M ^c   Gandolfo, S ^c   Puiatti, P ^c   Marietti, G ^d   Rizzetto, M ^b   Ponzetto, A ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d AMEDEO DI SAVOIA HOSPITAL   (Italy)

^e Ambulatori di Gastroenterologia   (Italy)

Author keywords

Autoimmunity; Cryoglobulinemia; Hepatitis C like viruses; Lichen planus oral; Tuberculosis

Indexed keywords

AGED; ARTICLE; CASE REPORT; FEMALE; HEPATITIS C; HUMAN; LICHEN PLANUS; MALE; MIDDLE AGED; PATHOLOGY; TUBERCULOSIS;

AGED; FEMALE; HEPATITIS C; HUMANS; LICHEN PLANUS; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; TUBERCULOSIS;

EID: 0034151242     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Hadziyannis SJ. The spectrum of extrahepatic manifestations in hepatitis C virus infection. J Viral Hepat 1997;4:9-28.
2. Jubert C, Pawlotsky JM, Pouget F, Andre C, DeForges L, Bretagne S et al. Lichen planus and hepatitis C virus-related chronic active hepatitis. Arch Dermatol 1994;130:73-6.
3. Gandolfo S, Carbone M, Carrozzo M, Gallo V. Oral lichen planus and hepatitis C virus (HCV) infection: is there a relationship? A report of 10 cases. J Oral Pathol Med 1994;23:119-22.
4. Saracco G, Rizzetto M. A pratical guide to the use of Interferons in the management of hepatitis virus infections. Drugs 1997;53:74-85.
5. Frider B, Sookoian S, Castagno G, Giavino G, Chouela E. Lichen planus, chronic hepatitis C and interferon. Hepatology 1995;21: 1764-5.
6. Doutre MS, Beylot C, Couzigon P, Long P, Royer P, Beylot J. Lichen planus and virus C hepatitis: disappearance of the lichen under interferon alpha therapy. Dermatology 1992;184(3):229.
7. Protzer U, Ochsendorf FR, Leopolder-Ochsendorf A, Holtermuller KH. Exacerbation of lichen planus during Interferon alpha-2a therapy for chronic active hepatitis. Gastroenterology 1993;104:903-5.
8. Vial T, Bailly F, Descotes J, Trepo C. Effets secondaires de l'interféron alpha. Gastroenterol Clin Biol 1996;20:462-83.
9. Davis GL. Hepatitis C. In: Schiff ER, Sorrell MF, Maddrey WC, editors. Schiff's diseases of the liver. Philadelphia: Lippincott-Raven Publishers, 1999:793-835.
10. Ince N, Wands JR. The increasing incidence of hepatocellular carcinoma. NEJM 1999;340:798-9.
11. International Interferon-α Hepatocellular Carcinoma Study Group. Effect of Interferon-α on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. Lancet 1998;351:1535-9
12. Dalekos GN, Christodoulou D, Kistis KG, Zervou EK, Hatzis J, Tsianos EV A prospective evaluation of dermatological side-effects during alpha-interferon therapy for chronic viral hepatitis. Eur J Gastroenterol Hepatol 1998;10:933-9.
13. Scully C, Beyli M, Ferreiro MC. Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med 1998;9:86-122.
14. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-20.
15. Pellicano R, Leone N, Maiocco IA, Modena V, Arena V, Marietti G et al. Chronic hepatitis due to HCV and cryoglobulinemia: the associated clinical spectrum. Minerva Med 1999;90:1-5.
16. Van Dis ML, Parks ET. Prevalence of oral lichen planus in patients with diabetes mellitus. Oral Surg Oral Med Oral Pathol 1995;79:696-700.
17. Carrozzo M, Gandolfo S, Carbone M, Colombatto P, Broccoletti R, Garzino-Demo P et al. Hepatitis C virus infection in Italian patients with oral lichen planus: a prospective case-control study. J Oral Pathol Med 1996; 25:527-33.
18. Mignogna MD, Lo Muzio L, Favia G, Mignogna RE, Carbone R, Bucci E. Oral lichen planus and HCV infection: a clinical evaluation of 263 cases. Int J Dermatol 1998;37:575-8.
19. Ingafou M, Porter SR, Scully C, Teo CG. No evidence of HCV infection or liver disease in British patients with oral lichen planus. Int J Oral Maxillofac Surg 1998;27:65-6.
20. Imhof M, Popal H, Lee JH, Zeuzem S, Milbradt R. Prevalence of hepatitis C virus antibodies and evaluation of hepatitis C virus genotypes in patients with lichen planus. Dermatology 1997;195:1-5.
21. Cribier B, Samain F, Vetter D, Heid E, Grosshans E. Systematic cutaneous examination in hepatitis C virus infected patients. Acta Derm Venereol 1998;78:355-7.
22. Lodi G, Porter SR. Hepatitis C virus infection and lichen planus: a short review. Oral Dis 1997;3:77-81.
23. Nagao Y, Sata M, Abe K, Tanikawa K, Kameyama T. Immunological evaluation in oral lichen planus with chronic hepatitis C. J Gastroenterol 1997;32:324-9.
24. Bertolini L, lacovacci S, Ponzetto A, Gorini G, Battaglia M, Carloni G. The human bone-marrow-derived B-cell line CE, susceptible to hepatitis C virus infection. Res Virol 1993;144:281-5.
25. Lerat H, Berthillon P, Habersetzer F, Berby F, Trabaud MA, Tremisi JC et al. Detection of hepatitis C virus RNA in peripheral and medullar hematopoietic cells. In: Rizzetto M, Purcell RH, Gerin JL, Verme G. Viral hepatitis and liver disease. Torino: Edizioni Minerva Medica, 1997.
26. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R et al. Binding of hepatitis C virus to CD81. Science 1998;282: 938-41.
27. Tanei R, Ohta Y, Katsuoka K. Lichen planus and Sjogren-type sicca syndrome in a patient with chronic hepatitis C. J Dermatol 1997; 24:20-7.